在体外代谢七种arolyl衍生的芬太尼类型的新精神活性物质
Xuan Luo1,2, Qiaotong Chen3, Kejian Huang4
1School of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, People's Republic of China. luoxuan@gxu.edu.cn.
Archives of toxicology
|January 3, 2025
概括
对芬太尼类新型精神活性物质 (F-NPS) 的法医分析是具有挑战性的,因为原始药物水平较低. 这项研究确定了arolyl衍生F-NPS的关键代谢物,有助于其检测和理解代谢.
科学领域:
- 法医化学 法医化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 芬太尼类型的新精神活性物质 (F-NPS) 是强大的合成阿片类药物,在生物样本中检测水平较低.
- 多种多样的F-NPS类型的快速出现,特别是来自arolyl的类型,使法医鉴定变得复杂.
- 代谢物是检测F-NPS的关键生物标志物,因为母药度低.
研究的目的:
- 为了研究七种arolyl衍生F-NPS的体外I期代谢.
- 阐明对胺水解,N-脱化和氧化等代谢途径的结构影响.
- 提供支持预测F-NPS体内代谢的数据.
主要方法:
- 在体外代谢使用人类肝脏显微体.
- 液体染色学-离子陷协同飞行时间质谱仪用于代谢物分析.
- 密度函数理论计算,以了解结构-代谢关系.
主要成果:
- 确定了主要的代谢途径,包括N-脱甲基化和β-单氧化,它们相互竞争.
- 胺基水解受碳基碳的电荷和基组替代物的影响.
- N-氧化和基单化显示出稳定的相对含量 (4%和13%).
- 在piperidine环的β-C位置的氧化形成一个单氧化代谢产物.
结论:
- 结构特征显著影响了基衍生F-NPS的代谢命运.
- 了解这些代谢途径对于准确的法医识别F-NPS至关重要.
- 这项研究为预测F-NPS的体内代谢提供了基础.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
218
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
218
Drug Metabolism: Phase I Reactions
3.0K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.0K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
178
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
178
Drug Metabolism: Phase II Reactions
3.6K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.6K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
139
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
139
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
80
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
80


